UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  ------------

                                    FORM 6-K

                                  ------------

                            REPORT OF FOREIGN ISSUER

                       Pursuant to Rule 13a-16 or 15d-16
                     of the Securities Exchange Act of 1934


                                  JUNE 22, 2007


                                  ------------

                                NOVO NORDISK A/S
             (Exact name of Registrant as specified in its charter)


                                    NOVO ALLE
                               DK-2880, BAGSVAERD
                                     DENMARK
                    (Address of principal executive offices)

                                  ------------

Indicate by check mark whether the registrant files or will file annual reports
under cover of Form 20-F or Form 40-F

                       Form 20-F [X]     Form 40-F [ ]


Indicate by check mark whether the registrant by furnishing the information
contained in this Form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

                             Yes [ ]     No [X]


If "Yes" is marked, indicate below the file number assigned to the registrant in
connection with Rule 12g-32(b):82-_____________________




ARTICLES OF ASSOCIATION

AS OF 19 JUNE 2007

1.    NAME

1.1   The Company's name is Novo Nordisk A/S.

1.2   The Company also carries on business under the names of:

      -     Novo Industri A/S (Novo Nordisk A/S)

      -     Novo Terapeutisk Laboratorium A/S (Novo Nordisk A/S)

      -     Nordisk Gentofte A/S (Novo Nordisk A/S)

      -     Nordisk Insulinlaboratorium A/S (Novo Nordisk A/S)


2.    REGISTERED OFFICE

2.1   The Company's registered office is situated in the municipality of
      Gladsaxe.


3.    OBJECTS

3.1   The Company's objects are to carry out research and development and to
      manufacture and commercialise pharmaceutical, medical and technical
      products and services as well as any other activity related thereto as
      determined by the Board of Directors. The Company strives to conduct its
      activities in a financially, environmentally, and socially responsible
      way.


4.    SHARE CAPITAL

4.1   The Company's share capital amounts to DKK 646.960.000 divided into A
      share capital of DKK 107,487,200 and B share capital of DKK 539.472.800 .

4.2   The share capital is divided into shares of DKK 1 or multiples thereof.
      One share certificate may comprise several shares.

4.3   The share capital has been fully paid up.



5.    SHARES AND REGISTER OF SHAREHOLDERS

5.1   The A shares shall be issued in the names of the holders and shall be
      entered in the holders' names in the Company's Register of Shareholders.
      The B shares shall be registered with VP Securities Services and be issued
      to bearer, and they may be registered in the names of the holders in the
      Company's Register of Shareholders upon request. Entry of a B share under
      the holder's name in the Company's Register of Shareholders shall be
      subject to the condition that the Company has been notified of such entry
      by VP Securities Services. The Company shall not be liable for the
      correctness of notifications received from VP Securities Services.

5.2   The A shares shall be non-negotiable instruments. The B shares shall be
      negotiable instruments.

5.3   In addition, the Articles of Association contain special rules as to the
      pre-emptive subscription rights of holders of A shares and B shares in
      connection with an increase of the share capital (Articles 6.1 and 6.2),
      as to the transferability of A shares (Articles 5.4-5.7), as to the voting
      rights carried by A shares and B shares (Articles 9.2 and 9.3), as to the
      dividend rights of A shares and B shares (Article 16) and as to the
      preferential rights of B shares to be covered in case of winding up
      (Article 17.2). In other respects, no shares shall carry special rights.

5.4   Where a shareholder wants to sell one or more A shares, such shares shall
      be offered to the Board of Directors on behalf of the other holders of A
      shares at a price not lower than the average of the buying price quoted
      for the B shares on the Copenhagen Stock Exchange during the last three
      months prior to the submission of such offer. The offer shall be
      accompanied by a certificate issued by a bank proving the stated average
      price. Where no price has been quoted for the B shares during the last
      three months prior to the submission of such offer, the A shares intended
      to be sold shall be offered at a price not lower than the value assessed
      for the B shares by a bank selected by the Board of Directors. Such
      assessment shall be the average of the prices estimated by such bank for
      each of the last three months prior to the submission of such offer.
      Within 30 days of receipt of such offer, the Board of Directors shall
      inform the shareholder whether other holders of A shares wish to acquire
      the shareholding in question. The purchase price shall be paid no later
      than two months after it has been fixed.


5.5   If the other holders of A shares do not exercise or do not fully exercise
      their preferential right to acquire the A shares offered, then the
      shareholder intending to sell shall be entitled - within a period of three
      months - to sell any shares that have not been acquired by the other
      shareholders to any third party on the same terms and conditions as those
      contained in the offer submitted to the Board of Directors according to
      Article 5.4 above.

5.6   Articles 5.4 and 5.5 shall not apply to any transfer of shares by
      inheritance or to a shareholder's transfer of shares during his lifetime
      to his spouse, issue, or to family foundations.

5.7   Articles 5.4 and 5.5 shall moreover apply to compulsory sales in
      connection with administration of estates or to proceedings or any other
      action taken by creditors.

5.8   No restrictions shall apply to the transferability of B shares.

5.9   No shareholder shall be obliged to have his shares redeemed in whole or in
      part.

5.10  Shares which have not been notified for registration by VP Securities
      Services and coupon sheets pertaining to such shares may be cancelled by
      the Board of Directors without any order of the court pursuant to the
      rules on cancellation contained in applicable law in force from time to
      time.


6.    INCREASE OF THE SHARE CAPITAL

6.1   In case the share capital is increased by issuance of A shares as well as
      B shares, the existing ratio between the two classes of shares must not be
      changed. In case of such an increase, holders of A shares shall have a
      pre-emptive right to subscribe for new A shares, and holders of B shares
      shall have a pre-emptive right to subscribe for new B shares.

6.2   Where the share capital is increased by either A shares or B shares, the
      holders of both classes of shares shall have proportionate pre-emptive
      subscription rights for the new A shares or the new B shares respectively.



6.3   Until 15 March 2009, the Board of Directors shall be authorised, without
      granting any pre-emptive rights to the shareholders, to increase the share
      capital in one or more stages by issuing B shares of up to DKK 20,903,400
      and to offer the shares to the employees of the Company or its
      subsidiaries at a price which is lower than the market price of the B
      shares.

6.4   Until 15 March 2009, the Board of Directors shall also be authorised,
      without granting any pre-emptive rights to the shareholders, to increase
      the share capital in one or more stages by issuing B shares of up to DKK
      100 million for the purpose of acquiring, in whole or in part, an existing
      enterprise. In these cases, payment is effected in other assets than cash.

6.5   Furthermore, until 15 March 2009, the Board of Directors shall be
      authorised to increase the share capital in one or more stages by up to
      DKK 100 million by cash payment.

      If the subscription price of the capital increase equals the market price
      of the B shares, the Board of Directors may decide that the capital
      increase shall be effected by the issue of B shares only and without any
      pre-emptive subscription rights for the shareholders.

      If the subscription price of the capital increase is lower than the market
      price of the B shares, the capital increase shall be distributed
      proportionally between A shares and B shares and with pre-emptive
      subscription rights for the shareholders.

6.6   The following shall apply to any increase of the share capital pursuant to
      Articles 6.3-6.5: (i) A shares shall be registered in the names of the
      holders, whereas B shares shall be issued to bearer, although they may be
      registered in the names of the holders in the Company's Register of
      Shareholders, (ii) A shares shall be non-negotiable instruments whereas B
      shares shall be negotiable instruments, (iii) the provisions of the
      Articles of Association relating to A shares and/or B shares,
      respectively, shall in addition be applicable.


7.    LOCATION, TIME AND CONVENING OF GENERAL MEETINGS

7.1   The Company in General Meeting shall, subject to Danish law and the
      limitations set out in the Articles of Association, exercise the ultimate
      authority over the Company.

7.2   General Meetings shall be held at a venue in the County of Copenhagen, in
      the City of Copenhagen, or in the municipality of Frederiksberg as
      determined by the Board of Directors.

7.3   The Annual General Meeting shall be held before the end of April in every
      year.

7.4   Extraordinary General Meetings shall be held as resolved by the Company in
      General Meeting or the Board of Directors, or upon the request of the
      auditor(s) or shareholders representing in total at least one tenth of the
      share capital. Such request shall be submitted in writing to the Board of
      Directors and be accompanied by specific proposals for the business to be
      transacted. The Extraordinary General Meeting shall then be called not
      later than two weeks after receipt of such request.

7.5   General Meetings shall be called by the Board of Directors at no more than
      four weeks' and no less than two weeks' notice, including the day of the
      notice calling the General Meeting and the day of the General Meeting. The
      notice calling such Meeting, stating the agenda for the meeting, shall be
      advertised in two national daily newspapers as determined by the Board of
      Directors.

7.6   The agenda and the complete proposals and, in the case of the Annual
      General Meeting, the audited Annual Report, shall be available for
      inspection by the shareholders at the Company's offices not later than
      eight days prior to any General Meeting and shall at the same time be sent
      to any registered shareholder on request.


8.    AGENDA, CHAIRMAN AND MINUTES OF GENERAL MEETINGS

8.1   Any shareholder shall be entitled to have specific proposals considered by
      the Company in General Meeting. Any such proposal(s) for the Annual
      General Meeting shall be submitted in writing to the Board of Directors
      not later than 1 February of the relevant year.

8.2   The agenda of the Annual General Meeting shall include the following:

      1.    The Board of Directors' oral report on the Company's activities in
            the past financial year.

      2.    Presentation and adoption of the audited Annual Report.



      3.    A Resolution to distribute the profit or cover the loss according to
            the adopted Annual Report.

      4.    Election of members to the Board of Directors.

      5.    Appointment of auditor(s).

      6.    Any proposals from the Board of Directors and/or shareholders.

      7.    Any other business.

8.3   General Meetings shall be presided over by a chairman, appointed by the
      Board of Directors. The chairman shall decide on all matters relating to
      the business transacted, the casting of votes and the results of voting.

8.4   The business transacted at the General Meeting shall be recorded in a
      minute book to be signed by the chairman.

8.5   The Board of Directors may decide that a General Meeting shall be held in
      English. All documents to be provided to the shareholders shall be in both
      Danish and English. The Board of Directors shall ensure that the Danish
      shareholders who are present at the General Meeting may participate in
      such meeting in Danish.


9.    RIGHT OF ATTENDANCE AND VOTING RIGHTS AT GENERAL MEETINGS

9.1   Any shareholder shall be entitled to attend and to vote at a General
      Meeting provided, however, that the shareholder has applied for an
      admission card to such General Meeting not later than five days prior
      thereto. Admission cards shall be issued to anyone who is registered as a
      shareholder in the Company's Register of Shareholders. Any shareholder who
      is not so registered shall document his shareholding by means of a
      statement of account which is not more than five days old issued by VP
      Securities Services or the account-holding bank (custodian bank) and shall
      at the same time issue a written statement to the effect that after the
      date of issue of the statement of account the shareholder has not sold the
      shares and does not intend to do so before the General Meeting has been
      held. Unless the shareholder states an address to which the admission card
      is to be sent, the admission card shall be collected at the Company's
      offices not later than the day before the General Meeting.

9.2   Any class A share of DKK 1 shall carry 10 votes.

9.3   Any class B share of DKK 1 shall carry 1 vote.

9.4   The voting right may be exercised by a proxy-holder, provided, however,
      that such holder substantiates his/her right to attend the General Meeting
      by presenting an admission card and a duly dated written instrument of
      proxy.


10.   RESOLUTIONS AT GENERAL MEETINGS, MAJORITY OF VOTES AND QUORUM

10.1  Resolutions by the General Meeting shall be passed by a simple majority of
      votes, unless stricter requirements are made under the Danish Companies
      Act or the Articles of Association.

10.2  Any resolution to amend the Articles of Association shall be subject to
      adoption by at least 2/3 of the votes cast and of the voting share capital
      represented at the General Meeting, unless stricter requirements are made
      under the Danish Companies Act.

10.3  Any resolution to amend the Articles of Association in accordance with
      Article 10.2 shall only be passed at one General Meeting, if at least 2/3
      of the total number of votes in the Company has been represented at the
      General Meeting ("the quorum requirement").

10.4  If the quorum requirement is not fulfilled, the Board of Directors shall
      within two weeks convene another General Meeting at which the resolution
      may be passed in accordance with Article 10.2 irrespective of the number
      of votes represented.

10.5  Any proxy to attend the first General Meeting shall, notwithstanding
      Article 9.4 and unless expressly revoked, be considered valid also in
      respect of the second General Meeting.



11.   BOARD OF DIRECTORS

11.1  The Board of Directors shall be in charge of managing the Company.

11.2  The Board of Directors shall consist of 4 to 10 members to be elected by
      the Company in General Meeting. Each member shall hold office for one year
      at a time. Retiring members may be re-elected.

11.3  The Board of Directors shall moreover include a number of members elected
      by the employees of the Company and its subsidiaries in accordance with
      applicable law thereon in force from time to time.

11.4  The Board of Directors shall elect one of its members as Chairman. The
      Board of Directors may also elect one of its members as Vice- chairman to
      act as substitute for the Chairman.

11.5  Board Meetings shall be convened and presided over by the Chairman. Board
      Meetings shall be convened if so requested by a member of the Board of
      Directors or by a member of the Management registered with the Commerce
      and Companies Agency.

11.6  The Board of Directors shall constitute a quorum when more than half of
      its members are present.

11.7  For the Board of Directors to pass a resolution, the vote of a simple
      majority of the members present is required. In case of a parity of votes,
      the Chairman shall hold the casting vote.

11.8  The Board of Directors shall lay down its own rules of procedure for the
      performance of its duties and exercise of its powers.

11.9  The business transacted at the Meetings of the Board of Directors shall be
      recorded in a minute book to be signed by all members of the Board of
      Directors.

11.10 The members of the Board of Directors shall receive an annual fee to be
      fixed at the Annual General Meeting in connection with the adoption of the
      audited Annual Report.


12.   MANAGEMENT

12.1  The Board of Directors shall appoint a managing director (President) to be
      in charge of the day-to-day management of the Company. The Board of
      Directors may also appoint up to eight additional managers (Executive Vice
      Presidents). All managers shall be registered with the Commerce and
      Companies Agency.


13.   POWERS TO BIND THE COMPANY

13.1  The Company shall be legally bound by the joint signatures of two Members
      of the Executive Management registered with the Commerce and Companies
      Agency or by the joint signatures of one such member of the Executive
      Management and the chairman or vice-chairman of the Board of Directors or
      by the joint signatures of all members of the Board of Directors.


14.   AUDITING

14.1  The audit shall be carried out by one state-authorised public accountant,
      unless more auditors are required under the law.

14.2  The auditor shall be appointed by the Annual General Meeting. The
      appointment shall be for a term of one year. The retiring auditor may be
      reappointed. An auditing company may be appointed auditor.


15.   FINANCIAL YEAR AND ANNUAL REPORT

15.1  The financial year of the Company shall be the calendar year.

15.2  The Annual Report shall give a true and fair view of the assets and
      liabilities, financial position and profits or losses of the Company and
      of the Group respectively, see the Danish Financial Statements Act in
      force from time to time.



16.   DISTRIBUTION OF DIVIDEND

16.1  Any profit according to the adopted Annual Report shall first of all be
      transferred to the necessary reserves. Dividend shall be distributed with
      a priority dividend of 1/2% to the holders of A shares and then, in
      priority, up to a dividend of 5% to the holders of B shares. Any
      distribution of additional dividends shall be subject to the provision
      that the holders of A shares shall never receive a total dividend
      exceeding the percentage rate of the dividend paid to the holders of B
      shares.

16.2  Dividends on A shares shall be remitted to the shareholders at the
      addresses entered in the Company's Register of Shareholders as at the date
      of the Annual General Meeting. Dividends on B shares shall be paid with
      fully discharging effect for the Company through VP Securities Services
      and an account-holding bank to shareholders registered by VP Securities
      Services at the time of payment. The right to dividends shall lapse five
      years after the due date of payment thereof.


17.   DISSOLUTION

17.1  Unless otherwise provided by Danish law, any resolution for the
      dissolution of the Company shall be passed by the Company in General
      Meeting in accordance with the provisions on the amendment of the Articles
      of Association (Articles 10.2-10.4). Where a resolution to dissolve the
      Company is passed, such dissolution shall be effected by voluntary winding
      up proceedings.

17.2  When distributing the proceeds of the winding up proceedings, the B share
      capital shall be covered in priority at its nominal value, following which
      the A share capital shall be covered in the same manner. The holders of A
      and B shares shall subsequently rank equally in proportion to their
      nominal holdings in respect of further distributions.


These Articles of Association were adopted on 19 June 2007 pursuant to
resolutions at the Company's Annual General Meeting held on 7 March 2007.



                                   Chairman:



                             ----------------------
                                 Klaus Sogaard




                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf of the
undersigned, thereunto duly authorized.

Date: JUNE 22, 2007                           NOVO NORDISK A/S
                             ---------------------------------------------------
                                            Lars Rebien Sorensen,
                                     President and Chief Executive Officer